ebocyte lysate assay may indicate the presence of fungus. This justifies early empiric antifungal treatment
itis in peritoneal dialysis patients have been analysed Introduction retrospectively. Limulus amoebocyte lysate results at presentation were compared with culture results. A Peritonitis is the most frequent complication of peritonLimulus amoebocyte lysate assay was performed using eal dialysis (PD). Drop-outs from PD due to peritonitis a commercial kit by incubating a mixture of dialysate have been reduced by improved connection techniques. effluent and Limulus amoebocyte lysate reagent at Early and effective treatment of peritonitis preserves 37°C. The development of a stable solid clot was the peritoneum and prevents the development of considered positive. The specificity and sensitivity of fibrosis and adhesions eventually leading to dialysis the test were calculated.
failure. Uncontrolled use of broad-spectrum antibiotics Results. The specificity of the Limulus amoebocyte may, however, have unwanted long-term effects such lysate assay was found to be 98% and the sensitivity as ototoxicity and reduction of residual renal function 74%. Limulus amoebocyte lysate assay was falseby aminoglycosides, or the development of resistant negative in 13 cases of Gram-negative peritonitis bacterial strains such as the vancomycin-resistant (22%). Limulus amoebocyte lysate was positive in three strains of Enterococci ( VRE) [1] . The significance of of seven cases of fungal peritonitis. The study included an accurate diagnosis of the organism, therefore, goes one case each with false-positive Limulus amoebocyte beyond the immediate benefit for the patient presenting lysate and with culture-negative peritonitis.
with peritonitis.
Conclusions. The Limulus amoebocyte lysate assay is
The early diagnosis of peritonitis is traditionally a convenient and valuable diagnostic tool for excluding based on clinical signs of peritoneal irritation, the Gram-positive peritonitis in peritoneal dialysis appearance of a cloudy peritoneal effluent or an patients. This allows more specific antibiotic treatment increased leucocyte count in the fluid. Antibiotic treatat presentation and may avoid the development of ment has to be initiated before an accurate diagnosis bacterial resistance. A negative Limulus amoebocyte has been established based on bacterial culture of the lysate test is not reliable for the exclusion of Gramdialysate effluent. Hence, treatment protocols initially negative peritonitis. In the absence of a positive culture recommend a combination of antibiotics covering both result 48 h after presentation, accompanied by a ide) can be detected in biological fluids by a 1-h test was 57.8±2.6 years (56.3±3.6 for males, 59.5±3.6 for females). The incidence of peritonitis during the known as the Limulus amoebocyte lysate (LAL) assay. LAL assays are the most sensitive tests currently period of observation was one peritonitis episode per 15.1 treatment months. known for endotoxin, with a theoretical detection limit of 500 Gram-negative bacteria/ml in peritoneal dialysWe compared bacteriological culture results with the respective results of the LAL assay. A Gram-positive ate effluent [4, 5] . The LAL test also yields positive results when a fungus is the infective organism [6 ] . agent was identified in 40% of cases (44/111) and a Gram-negative agent in 53% of cases (59/111). Fungal Previous studies evaluating LAL testing in peritonitis of CAPD patients included 3-17 episodes of Gram-peritonitis was diagnosed in 5% of cases (7/111) and one episode of peritonitis was culture negative. negative peritonitis. Reported sensitivities vary between 65 and 100% [3, 5, 7] . This retrospective study
The LAL assay was false-negative in 15% of cases. This included 13 cases of Gram-negative peritonitis was conducted to assess the value of the qualitative gel clot LAL test in the early diagnosis of peritonitis and four cases of fungal peritonitis. Thus, 22% (13/59) of Gram-negative organisms and 57% (4/7) of fungi in CAPD patients.
were associated with false-negative results. No specific pattern could be discerned in the distribution of Gramnegative species yielding false-negative results. Only
Methods one false-positive result was found, caused by Streptococcus sanguinis (1%) ( Table 1 ).
Patient population
Overall specificity and positive predictive value were both 98%, whereas sensitivity was found to be 74%
Records of all CAPD patients treated at our centre between and negative predictive value 72%.
1995 and 1998 were reviewed. All episodes of peritonitis were recorded. Abdominal pain, cloudy peritoneal effluent or more than 100 leucocytes/mm3 in the effluent were considered positive criteria for the clinical diagnosis of peritonitis. The Discussion diagnosis was further confirmed by laboratory analysis of peritoneal effluent solutions.
This retrospective study underscores the high specificity At presentation, peritoneal effluent samples were obtained (98%) and positive predictive value (98%) of the qualitfrom dialysate bags using a sterile 18-gauge needle and ative gel clot LAL test in the diagnosis of peritonitis syringe from the alcohol-swabbed stopper port. Effluent was in PD patients. Thus, a Gram-positive infection saved at 4°C for the LAL assay, which was performed the may be excluded with a high degree of certainty if the same day, and was also incubated in bacteriological culture LAL test is positive. According to our study 45% media (Bactec, Becton Dickinson, MD, USA).
The LAL assay was performed in duplicate using commer-(50/111) of all patients with peritonitis have a positive cial LAL reagent containing Limulus amoebocyte lysate in LAL test at presentation. In 49 of 50 cases the LAL its haemolymph (Charles River Endosave, Charleston, SC, test is true positive. This finding is significant because USA). The assay was performed in pyrogen-free test tubes in these patients, based on LAL testing, antibiotic to which 0.1 ml of peritoneal effluent solution and 0.1 ml of treatment against Gram-positive organisms may be LAL reagent were added. Following 1 h of incubation at safely omitted from their initial empirical management. 37°C, the test tubes were examined by 180°inversion for the If relying only on culture results treatment would be presence of a stable solid clot. A clotted incubation mixture adjusted and narrowed with an average delay of 48 h. was considered to be a positive result. Endotoxin standard
The elimination of antibiotics in the initial phase of (Escherichia coli strain O555B5, 0.125 EU/ml ) and pyrogenperitonitis will be more pronounced in patient populafree LAL reagent water, both provided by the manufacturer, were used as a control. A labelled LAL reagent sensitivity tions with higher incidences of Gram-negative peritonof 0.125 EU/ml was confirmed by serial dilutions prior to use. itis. In our patient population, the incidence of Gramnegative peritonitis was 53%, contrasting with other centres that report incidences of~15% [8] . Staphylococcus epidermidis due to the introduction of disconnect systems [8, 10] . Thus, during 1984-1987, 35% of episodes at our institution were caused by S.
Results
epidermidis, whereas in the present study S. epidermidis was the cause of only 13% of peritonitis episodes. Racial and educational differences may also contribute Data from 111 episodes of peritonitis in 54 patients (30 males, 24 females) were reviewed. The average age to differences in peritonitis rates [8, 11] . Sterile  Total   LAL-positive  46  1  3  50  LAL-negative  13  43  4  1  61  Total  59  44  7  1  111 Narrowing the choice of empirical treatment at the sensitivity of the LAL test from 0.12 EU/ml to 0.5 EU/ml compared with distilled water [3] . The LAL presentation is likely to lower the incidence of resistance to antibiotics. Because of emerging strains of test may also be false-negative because it does not detect small molecular mass endotoxins [22] . In our VRE and S. aureus [12] current recommendations include first-generation cephalosporins, rather than study, false-negative results of the LAL assay could not be attributed to a specific organism. Indeed, differvancomycin, in the initial treatment of peritonitis [2] . The indiscriminate use of first-generation cephalospor-ent bacteria and strains of the same bacteria differ in their ability to release endotoxins from their surfaces ins may contribute to the selection of ceftazidimeresistant Gram-negative bacilli, although their use has [23] . This is likely to affect the LAL assay since cell-bound endotoxin has a lower Limulus activity than not been shown to lead to antibiotic resistance in a PD population [13, 14] . Also, substitution of cephalos-shedded endotoxin [24] .
Whereas 22% of Gram-negative infections were assoporin for vancomycin may not be implemented in institutions in which the rates of methicillin-resistant ciated with LAL-negative results, 57% of fungal infections were LAL-negative. This difference in sensitivity S. aureus or S. epidermidis are high. Reported rates of methicillin resistance are 15-20% for S. aureus and is consistent with the reported lower in vitro sensitivity of LAL tests to LAL-reactive glucans than to endotox-30-40% for S. epidermidis [15, 16 ] . Reliable and convenient LAL testing, as used in this study can, there-ins [25] . The fungal cell-wall content of beta glucans is variable. It depends on other cell-wall components fore, contribute significantly to clinical management of the patient.
and is regulated by genes [26, 27] . Also, fungal beta 1,3 chains of -glucan have variable degree of 1,6 The LAL assay used here is not specific for Gramnegative bacteria since fungal infections may also cause branching which affects LAL reactivity [28] .
The gel clot LAL assay used in this study is a positive results due to (1 3)-beta glucans which form a major structural component of fungal cell walls. practical tool, in that the time required for incubation is 1 h. The cost per assay is $3, whereas expenses for Endotoxin and glucan activate C and G compounds, respectively, which are clotting enzymes contained in controls add $7. The surplus investment for assays of PD effluents is negligible in a laboratory where LAL amoebocyte granules. Several specific assays containing only G compound have been developed to detect assays are routinely performed for the quality control of the haemodialysis water supply. glucan without interference from endotoxin [17] . In our study, three of seven episodes of fungal peritonitis
In conclusion, the gel clot LAL assay is a reliable and convenient diagnostic tool to exclude Gramwere LAL positive at presentation and initially culturenegative. In these patients, specific antifungal therapy positive peritonitis in CAPD patients because of its high specificity of 98%. A positive test justifies selective was delayed for up to 11 days until culture results were available. Empirical antifungal therapy may be indi-treatment with aminoglycosides only. If culture results turn out to be negative and the patient does not cated in patients with a LAL-positive test and initially negative culture not responding to conventional anti-respond to the empirical treatment, the addition of specific antifungal therapy should be considered. A biotic treatment. This will ensure specific treatment within 48 h of presentation and possibly lower drop-negative test does not exclude Gram-negative infection and warrants broad-spectrum antibiotic treatment until outs from CAPD due to membrane failure.
Originally, LAL assays were expected to be useful culture results are available. Routine LAL testing of peritoneal effluents from CAPD patients presenting for the early detection of Gram-negative infections. They have been applied to the diagnosis of meningitis, with peritonitis is advised. intra-amniotic or biliary infections [18] [19] [20] , as well as to the diagnosis of bacterial peritonitis in CAPD
